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Conclusion. Albumin concentration in dialysis patientsRelationships among inflammation nutrition and physiologic
changes with inflammation and nutritional status through theirmechanisms establishing albumin levels in hemodialysis patients.
effects on albumin catabolism and synthesis, respectively. WithinBackground. Serum albumin concentration is a balance among
the range of albumin levels in these patients, nutritional variablesits synthesis rate, fractional catabolic rate (FCR), distribution,
primarily affected albumin synthesis while inflammation causeddilution in the plasma pool and external loss. The physiologic
hypoalbuminemia by increasing albumin FCR. Albumin syn-bases for establishing the level of serum albumin in hemodialy-
thesis also increased in proportion to PV. The result of this issis patients have not been defined despite the association of
that PV expansion does not contribute to hypoalbuminemia.hypoalbuminemia with excess mortality. Albumin concentra-
tion is associated with the levels of several acute phase pro-
teins (APPs), C-reactive protein (CRP), 1 acid glycoprotein
(1 AG), or ceruloplasmin, and with nutritional markers, such Hypoalbuminemia is a powerful predictor of mortalityas normalized protein catabolic rate (nPCR).
in dialysis patients [1, 2]. Inflammation itself alters albu-Methods. To establish the relationship among parameters
min levels. Low albumin levels and mortality correlatethat regulate albumin levels and markers of nutrition and in-
flammation, we injected [125I]-albumin, into 64 hemodialysis pa- with markers of inflammation, either cytokines [3], or acute
tients enrolled in the HEMO study to measure albumin distri- phase proteins [4, 5]. Several investigators have proposed
bution, synthesis and FCR. These variables were related to the
that the process is a reduced rate of albumin synthesislevels of acute phase proteins (APPs), nPCR, body mass index
[6] based on the finding that albumin mRNA and synthe-(BMI), external albumin loss as well as demographic variables.
Albumin distribution, synthesis and FCR were calculated from sis in the liver is reduced following trauma [7] or adminis-
kinetic modeling, as was the initial plasma volume (PV). Serum tration of either cytokines [8] or endotoxin [9, 10].
albumin, transferrin, CRP, ceruloplasmin and 1 AG were mea- The finding that the absolute rate of albumin synthesis
sured weekly. Dialysate was collected during one dialysis each
is decreased in the presence of inflammation or trauma byweek to measure albumin loss. Results were analyzed by multi-
no means, however, has been uniform. Ruot et al notedple linear regression.
Results. Albumin concentration correlated with its synthesis that albumin mRNA and albumin synthesis relative to
rate and FCR, but not with PV or its distribution between the total hepatic mRNA and total hepatic protein synthesis
vascular and extravascular pools. Albumin concentration also decreased in the livers of rats with sepsis, although thecorrelated with nPCR and 1 AG. However, albumin synthesis
absolute rate of albumin synthesis did not decrease [11].was directly related most strongly to PV and BMI (or nPCR),
The rats developed hypoalbuminemia, but the investiga-but not to levels of APPs. By contrast, albumin FCR correlated
positively with both 1 AG and ceruloplasmin. tors concluded that the mechanism was not one of de-
creased albumin synthesis. Instead, fractional albumin
synthetic rate increased, suggesting that the primaryKey words: albumin synthesis, fractional catabolic rate, plasma volume,
cause of hypoalbuminemia was an increase in albuminacute phase, C-reactive protein, ceruloplasmin, 1 acid glycoprotein,
nutrition, body mass index, nPCR. FCR. Von Allmen, Hasselgren and Fischer reported that
albumin synthesis in rats was increased by four daysReceived for publication July 31, 2001
after sepsis induced by celiac puncture [12], and Koj andand in revised form January 3, 2002
Accepted for publication January 28, 2002 McFarlane found that albumin synthesis was actually
increased following endotoxin injection [13]. The rate of 2002 by the International Society of Nephrology
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albumin synthesis also has been reported to be increased years). Thirty-two patients were African American, and
38 patients had diabetes mellitus. Renal failure was causedin patients following head trauma, despite a decrease in
serum albumin concentration [14]. Similarly, albumin by hypertension in 14 patients, 9 patients had glomerulo-
nephritis, 2 had adult polycystic kidney disease, one hadsynthesis was increased in hypoalbuminemic cancer pa-
tients [15]. Thus, the conclusion that trauma- or sepsis- systemic lupus, one had chronic pyelonephritis, one had
acute renal failure, one had analgesic nephropathy, oneinduced hypoalbuminemia is due to suppression of albu-
min synthesis is controversial. had been nephrectomized because of renal cell carcinoma,
and the remainder had renal failure of uncertain etiology.The concentration of any protein in plasma is a func-
tion of its rate of synthesis, its fractional catabolic rate Thirty-one patients had a subcutaneous polytetrafluoro-
ethylene (PTFE) graft, 25 had arteriovenous fistulas and(FCR) plus external loss and its volume of distribution.
We previously established that hypoalbuminemic hemo- eight had a semi-permanent transcutaneous access (Perm-
cath).dialysis patients had a decreased rate of albumin synthe-
sis when compared to those with a normal albumin con- Nine patients were dialyzed using a F80 B (Fresenius
Medical Care AG, Bad Homburg Germany), 12 with acentration [16]. Those results were obtained in two small
groups of patients, six each, selected from the lowest and F80 A, 26 using a F 8 (Fresenius) one with a F 6 (Fresenius),
five using a CA210 dialyzer (Baxter Healthcare Corpora-highest quartiles of albumin concentration in the avail-
able population. While there was no difference in dietary tion, Deerfield, IL, USA), seven using a CT190G dialyzer
(Baxter), and three using CT 190, (Baxter) dialyzer. Allcalorie or protein intake between these two groups there
was evidence for activation of the acute phase response of these dialyzers were subjected to reuse with bleach/
formaldehyde or hot citric acid. One patient was dialyzedin those with hypoalbuminemia. To investigate the rela-
tionships among albumin synthesis and catabolism and with a Filtral 20 dialyzer (Hospal, Boca Raton, FL, USA)
without reuse. All dialysis was performed using bicar-serum concentration in dialysis patients more completely
and to identify determinants controlling albumin synthe- bonate-based dialysate at a delivered bicarbonate con-
centration of 39 mEq/L.sis in hemodialysis patients, we measured albumin distri-
bution and turnover rate in 64 hemodialysis patients who
Method of measuring albumin turnoverwere participating in the National Institutes of Health
sponsored hemodialysis (HEMO) study of morbidity Approximately 10 Ci of [125I] albumin was injected
into a peripheral vein and blood samples of about 3 mLand mortality in dialysis patients [17]. The patients re-
ported here were sequentially recruited to an ancillary obtained periodically until plasma [125I] levels decreased
to 5% of original counts (in practice this required sam-study to measure albumin synthesis and markers of in-
flammation longitudinally and survived the six week pe- pling for between 600 and 900 hours, that is, 25 to 38
days). Initially blood was sampled at 15, 30 and 60 min-riod following injection of [125I] albumin in order to per-
mit accurate kinetic modeling of albumin turnover and utes, then at three and five hours. Thereafter blood was
drawn prior to and following each hemodialysis for thedistribution.
600 to 900 hour period. Three 400-L aliquots of from the
sample were then counted in a gamma counter (Searle,
METHODS
Analytics, Des Plaines, IL, USA) for 10 minutes. The
Patient selection plasma radioactivity disappearance curve was integrated
by use of the numerical model using SAAM II [18].The individual Institutional Review Boards at each
institution approved the protocol and informed consent Prior to counting, serum was precipitated using 10%
trichloroacetic acid (TCA) to remove non-protein boundwas obtained from each patient. Sixty-four patients en-
rolled in the National Institutes of Health HEMO Study 125I and then redissolved in 1 N NaOH.
The average value for serum albumin concentrationat the University of California Davis (Sacramento, CA),
at Beth Israel Medical Center (New York, New York) measured during the first day of the study (taken prior
to dialysis) did not vary from the average pre-dialysisand at Emory University (Atlanta, GA) were recruited
to participate in a longitudinal study of the relationship albumin values obtained throughout the six week period.
However, the average serum albumin concentration be-between the levels of acute phase proteins and serum
albumin concentration. All patients who had been ran- tween the pre- and post-dialysis values for individual pa-
tients was significantly different. Serum albumin concen-domized into one of the four HEMO treatment groups
were eligible for enrollment in this study. During the tration increased, sometimes by a considerable amount
because of hemoconcentration during dialysis. The spe-initial six weeks albumin turnover rate was measured as
previously described [16]. cific radioactivity of albumin, however, did not change
between the pre- and post-dialysis values. Because albu-The 64 patients had been on dialysis for a mean time
of 6.44  3.45 years (range 1.32 to 21.56 years; median min concentration was different at the beginning and at
the end of hemodialysis, we were concerned that the clear-6.40 years; 25th percentile, 3.73 years; 75th percentile, 7.68
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ance of albumin would be either overestimated, by using time since injection in hours, and C is TCA precipitable
counts/mL of plasma. Since a concentration term is in-only the predialysis albumin concentration, or clearance
underestimated by using only the post-dialysis concen- cluded at each time point integrated, this relationship
yields a mass term rather than a volume term.trations of albumin for the integration. Furthermore, it
was not clear which average plasma albumin value Recognizing that specific radioactivity is counts/unit
mass of albumin:should be used in the calculation of albumin turnover
once the albumin clearance had been established. We
used specific radioactivity rather than absolute counts
because the use of specific radioactivity does not require TAM  D ·

∞
0
t · SA · dt

∞
0
SA · dt
2 (Eq. 4)
the assumption that plasma albumin remains constant
and all albumin measurements can be used. Instead of
obtaining a clearance term, the integration yielded a rate where SA is specific radioactivity of serum albumin in
for albumin turnover in mg · h1 directly. counts/min/mg of albumin.
Total albumin turnover 
D

∞
0
1
A
· C · dt
(Eq. 1) Method of measuring trans-dialyzer albumin loss
We also determined the effect of trans-dialyzer albu-
min losses on albumin homeostasis. Since collection of
all dialysate from a given treatment is cumbersome, thewhere D is the total number of counts injected at time
value obtained was compared by proportionally splitting0 (dose), A is albumin concentration in mg/mL at each
the stream throughout a treatment (this technique col-time point, and C is the trichloroacetic acid (TCA) pre-
lected 1% of the total dialysate) versus collecting spotcipitable counts/mL of serum. Specific radioactivity is
samples and then estimating total albumin losses fromC/A at each time point. Unit analysis reveals that counts/
that concentration and the dialysis flow rate [16].min cancel and we are left with total albumin turnover/
Albumin fractional catabolic rate (FCR) was calcu-unit time.
lated as the percent of the plasma albumin pool removedRecognizing that specific radioactivity is counts/min/
per day, assuming a steady state minus measurable albu-mg of albumin:
min losses. Since these patients were anuric and there
were no urinary albumin losses, only the average dailyTotal albumin turnover 
D

∞
0
SA · dt
(Eq. 2)
dialysis losses through the dialyzer were used for this
calculation. For this value we used the average loss dur-
ing each dialysis session times 3/7, to account for the factwhere SA is counts/min/mg of serum albumin (specific
that dialysis was only delivered three days a week.radioactivity).
Plasma volume was calculated by isotope dilution: the FCR  (Turnover rate 
counts of [125I] obtained during the first 60 minutes af-
measured albumin losses)/PAM (Eq. 5)ter the injection were extrapolated to t  0. Plasma
albumin mass (PAM) is the product of initial plasma Laboratory methods
albumin concentration (the average of serum albumin
Serum albumin obtained at each point on the day ofconcentration from each time point during the first hour)
injection of [125]I albumin, and then prior to and followingand plasma volume.
each dialysis for the six week period was measured in du-Similarly, specific radioactivity was used to directly
plicate using bromcresol green. All other proteins (trans-calculate total albumin mass, rather than first calculating
ferrin, ceruloplasmin and 1 AG) were measured ini-a steady state volume of distribution (VDss) [19, 20], so
tially and then weekly by rate nephelometry using aas to utilize all albumin values measured during kinetic
Beckman Array automated nephelometer (Beckman In-analysis rather than an average value for serum albumin
struments, Fullerton, CA, USA) [21]. Albumin in dialy-concentration. Total albumin mass was calculated di-
sate was also measured using nephelometry, with a lowerrectly, without calculating its volume of distribution first:
limit of detection of 2 mg/L. All nephelometric measure-
ments were made in duplicate in each of two optical
systems. The average of these values was used for calcu-
TAM  D ·

∞
0
t
A
· C · dt

∞
0
C
A
· dt
2
(Eq. 3) lations. The intra-assay coefficient of variation for albu-
min was 0.22%, with an inter assay coefficient of varia-
tion ranging from 2.42% to 3.16% over the usable range
of the assay. The intra-assay coefficient of variation forwhere D is the total counts injected (dose), A is the
plasma albumin concentration at each time point, t is 1 acid glycoprotein was 0.14%, with an inter-assay coef-
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ficient of variation ranging from 3.07% to 5.50% over ingly, of the acute phase proteins only 1 AG correlated
with albumin turnover and the correlation coefficientthe usable range of the assay. The intra-assay coefficient
of variation for ceruloplasmin was 0.27%, with an inter- was positive.
The relationships between albumin concentration andassay coefficient of variation ranging from 4.44% to 9.18%
over the usable range of the assay. The intra-assay co- that of acute phase proteins and nPCR that had been pre-
viously reported also were evaluated [23, 24]. We foundefficient of variation for transferrin ranged from 0.026%
to 0.07%, with an inter-assay coefficient of variation rang- that this relationship remained significant for both albu-
min and CRP (after log transformation; Fig. 1) or foring from 2.56% to 4.38%.
Normalized PCR was measured monthly using a dou- 1 AG (Fig. 2) or ceruloplasmin. Having established this,
we then analyzed whether the concentration of any ofble pool method [22].
the acute phase proteins interacted in any way with any
Summary of the statistical analysis for predicting of the determinants of serum albumin concentration other
albumin synthesis than albumin synthetic rate.
Once the albumin fractional catabolic rate (FCR) wasTo determine the factor that principally determined
albumin concentration, first, multiple regression analysis established as one determinant of initial albumin concen-
tration, further analysis was performed to determine thewas performed using the initial value of serum albumin
concentration in our cohort of 64 hemodialysis patients relationships between albumin FCR and acute phase
protein and serum albumin concentration.as the dependent variable and a function of albumin syn-
thetic rate (turnover /1.73 m2), fractional catabolic rate A number of variables used are normalized to adjust
for differences in body mass and composition. Albumin(FCR; % of the plasma pool that was removed per day
after subtraction of the amount lost through the dialysis turnover was adjusted for body surface area [BSA (m2)
0.007184 * kg 0.425 * cm0.725], BMI was a measure of bodymembrane), plasma volume as % body weight (PV) and
distribution of albumin between the vascular and extra- composition by adjusting weight for height (kg/m2), and
vascular compartment established kinetically (that is, plasma volume is adjusted for body size as percent body
plasma albumin mass/total albumin mass; (PAM/TAM). weight. To assure that our results were not a consequence
The initial albumin concentration was calculated as the of artifactual coupling of these parameters the results
first six-week average for albumin after injection of [125]I also were analyzed using total albumin turnover, abso-
albumin. All other averages for the other longitudinally lute plasma volume, absolute protein catabolic rate and
collected proteins (and nPCR) were also the first six- body weight as variables.
week average value.
Specific biochemical and demographic variables (lev-
RESULTSels of acute phase proteins, age, cause of renal failure)
Table 1 shows the baseline characteristics of patientsalso could influence baseline albumin concentration,
that were included in the model, plus the average concen-and so a separate regression model was constructed for
trations of CRP, transferrin, ceruloplasmin, and 1 AGbaseline serum albumin concentration as a function of
during the six week period of observation. There wasthese variables.
no significant difference between the average plasma al-The next goal was to fit a regression model for albumin
bumin concentration averaged over the entire period ofturnover rate to results from the cohort. To achieve this,
the turnover study and the initial serum albumin concen-we examined a number of potential predictors including
tration so the average albumin value was shown. Albu-CRP: 1 AG, ceruloplasmin, transferrin, nPCR, initial
min turnover rate, plasma mass and total mass wereplasma volume percent (expressed as % body weight),
normalized by body surface area and plasma volume asBMI, age, vascular access (fistula, AV graft, or transcuta-
percent body weight.neous access), ethnicity (African American, Caucasian,
Significant albumin losses could only be detected in 7Hispanic, Asian), gender, and the presence or absence of
of the 64 patients and these were primarily related todiabetes. There were insufficient numbers of patients
use of CT 190 dialyzers (even without reuse) or F80Bhaving other causes of renal failure to perform meaning-
dialyzers after reuse with bleach (albumin loss did notful analysis based on other causes of renal failure. All
begin before reuse 4). By contrast, albumin losses couldnon-African American patients were combined for sta-
be detected with the CT 190 dialyzers even with the firsttistical analysis because of the low numbers of other
use led to losses of 0.38  0.086 g/dialysis treatment.ethnic groups.
Reuse with bleach, but not with other methods increasedThe albumin synthesis rate correlated most strongly
the amount of albumin lost by either CT 190 or F80Bwith plasma volume and with either nPCR or with body
dialyzers. The maximum loss recorded with the CT 190mass index (BMI). If both the latter were entered into
occurred with the 20th reuse bleach (4.24 g/dialysis). Thethe regression model, BMI eliminated nPCR as a pre-
dictor of albumin synthesis rate. Significantly and surpris- maximum loss with the F80B was only 1.15 g (on the
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Fig. 1. (A) Relationship between serum albumin concentration (g/dL), nPCR and C-reactive protein (CRP; after log transformation). Albumin 
3.785  (0.185 * Log CRP)  (0.258 * nPCR); r 2  0.145; log CRP, P  0.047, nPCR P  0.04. The surface is a best fit model extrapolated using
the method of least squares. The symbols represent values obtained from the individual patients. The vertical line descending from each symbol
is to orient the symbol to the XY plane. (B) Relationship between serum albumin concentration, nPCR and 1 acid glycoprotein. The surface
and symbols are as described in panel A. Albumin  4.109  (0.00205  1 AG)  (0.229  nPCR); r 2  0.135; 1 acid glycoprotein, P  0.026;
nPCR, P  0.023.
19th reuse); and during the 20th reuse, it was 0.69 
0.30 g/treatment with this dialyzer. The maximum average
albumin loss observed by any patient, however, was only
1.8 g in one patient, and among the 6 in whom any loss
was measured the mean loss was 0.532 g/treatment. Thus,
extracorporeal albumin losses played no significant role
in establishing serum albumin concentration in this group
of patients.
The age of the patients ranged from 19 to 81 with a
median value of 58.5 years. The 25th percentile was at
49.5 years and the 75th percentile at 69 years. There
were 37 males and 27 females in the population. We
first examined the relationship between serum albumin
concentration and the demographic and laboratory vari-
ables: 1 AG, ceruloplasmin, CRP (after log transforma-
Fig. 2. Relationship between albumin fractional catabolic rate (FCR) tion), transferrin, nPCR, BMI (body weight/height2),
and 1 acid glycoprotein (1 AG). FCR  9.309  (0.0209  1 AG); age, gender, ethnicity (African American vs. other eth-P  0.023. The regression is presented as the least squares fit (solid
line) with 95% confidence levels (dashed lines). nicity), presence of diabetes, and type of vascular access.
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Table 1. Mean values for all parameters
Parameter Mean SD Maximum Minimum Median 25% 75%
Albumin g/dL 4.10 0.254 4.77 3.62 4.13 3.89 4.27
CRP mg/dL 0.992 1.008 4.30 0.075 0.51 0.316 1.61
1 AG mg/dL 115 34.2 239 60.6 114 88.3 135
Ceruloplasmin mg/dL 38.4 8.22 56.5 21.4 38.1 32.0 41.6
Transferrin mg/dL 180 30.594 241 112.85 182.167 157.67 205
nPCR g/kg/day 1.00 0.313 2.09 0.521 0.923 0.8 1.23
Surface area m2 1.77 0.23 2.25 1.228 1.77 1.61 1.95
Synthesis g/1.73 m2/day 15.1 3.372 23.9 8.551 14.779 12.819 16.9
PAM g/1.73 m2 130 30.141 212 76.334 127.186 108.938 146
TAM g/1.73 m2 341 90.581 693 178.58 332.081 289.626 379
PAM/TAM 0.392 0.0711 0.622 0.200 0.388 0.346 0.437
Dialysate albumin loss g/1.73 m2 0.0269 0.109 0.774 0.10 0.10
FCR %/day 11.7 2.504 19.6 7.105 11.066 10.1127 13.2
BMI kg/m2 23.7 4.45 3.33 12.0 23.3 20.9 27.3
Abbreviations are: CRP, C-reactive protein; 1 AG, 1 acid glycoprotein; nPCR, normalized protein catabolic rate; PAM, plasma albumin mass; TAM, total
albumin mass; FCR, fractional catabolic rate; BMI, body mass index.
Table 3. Relationship between albumin synthesis, catabolismTable 2. Demographic, inflammatory and nutritional determinants
of serum albumin concentration and distribution and serum albumin concentration
in hemodialysis patients
Coefficients: Value Standard error t value P
Coefficients: Value Standard error t value P
(Intercept) 4.287 0.233 18.368 0.00001
1 AG 0.002 0.001 2.318 0.024 (Intercept) 4.77 0.392 12.188 0.001
Synthesis rate 0.039 0.016 2.447 0.017nPCR 0.208 0.096 2.177 0.034
Age 0.004 0.002 1.618 0.111 PV % 0.067 0.040 1.695 0.095
FCR 0.055 0.023 2.402 0.020Gender 0.118 0.06 1.955 0.055
PAM/TAM 0.749 0.523 1.433 0.157Potential predictors used for this regression were: log.CRP, 1 AG, ceruloplas-
min, transferrin, nPCR, BMI, age, gender, ethnicity (analyzed as black vs. other Potential predictors were albumin synthesis rate (Synthesis rate), plasma vol-
ethnic groups), cause of renal failure (analyzed as diabetes vs. other cause), and ume expressed as percent body weight (PV %), albumin fractional catabolic rate
access as fistula vs. AV graft vs. transcutaneous access. One outlier was removed (FCR), the ratio of plasma albumin mass to total albumin mass (PAM/TAM).
from model due to a serum albumin less than 2 SD below the mean value, N  One outlier was removed from model because of reduced albumin concentration
63. Abbreviations are in Table 1. Residual standard error for the regression was (same patient as in model from Table 2). Residual standard error for the regres-
0.231 with 58 degrees of freedom. Multiple R2 was 0.226. F-statistic: 4.23 on 4 sion was 0.245 on 58 degrees of freedom. The multiple R2 for the regression was
and 58 degrees of freedom, with a P value of 0.00448. 0.128. The F-statistic was 2.13 on 4 and 58 degrees of freedom, with a P value
of 0.088.
One patient had a serum albumin concentration that was
Of these, the influence of serum albumin concentrationgreater than 2 standard deviations from the mean of the
did not achieve statistical significance. When only thegroup and was not included in this analysis for this rea-
relationship between FCR and any of the acute phaseson. Therefore, results from 63 patients were used for
proteins were examined by linear regression analysis,these analyses. Of these variables, the ones that were
both 1 AG (P  0.023) and ceruloplasmin (P  0.013)included in the final model (maximum adjusted r 2) were
correlated positively with FCR (Figs. 3 and 4). Notably,age, gender, nPCR and 1 AG; only 1 AG and nPCR
this was not true for CRP, as its relationship with FCRreached statistical significance (Table 2).
either with or without log transformation was not sig-Next, the relationship between serum albumin concen-
nificant (P 0.127). The only demographic variable thattration and only these variables was evaluated (Table 3).
correlated with either CRP or 1 AG was age (P Serum albumin concentration correlated positively with
0.0046 for 1 AG and P  0.0495 for CRP).its rate of synthesis and inversely with its FCR. While the
Albumin synthetic rate was most powerfully con-distribution of albumin between the plasma and extra-
trolled by plasma volume and BMI (Table 5), althoughplasma compartment (PAM/TAM) did not significantly
age, nPCR and 1 AG also entered into the model thataffect serum albumin concentration, there was a tendency
was found to have the highest adjusted r 2 value. If BMIfor serum albumin concentration to decrease when ad-
was excluded from the regression model, then albuminjusted for the rate of albumin synthesis and FCR.
synthesis was predicted by plasma volume and nPCRThe factors that controlled the two principal determi-
(P  0.0046).nants of albumin concentration—FCR and albumin syn-
As PV increased so did the rate of albumin synthesis,thetic rate—were analyzed. Albumin FCR is a function
and as BMI (or nPCR) increased so did albumin synthe-of 1 AG, a marker of inflammation, BMI, a nutritional
marker, age, and serum albumin concentration (Table 4). sis. We suspected that there was an interaction between
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Table 4. Determinants of albumin fractional catabolic rate
Coefficients: Value standard Error t Value P
(Intercept) 3.507 4.3 0.816 0.418
Alb 1.135 0.859 1.321 0.191
1 AG 0.03 0.009 3.447 0.001
BMI 0.173 0.061 2.823 0.006
Age 0.053 0.02 2.631 0.011
Potential predictors used were serum albumin concentration (Alb), log CRP,
1 AG, ceruloplasmin, transferrin, nPCR, BMI, age, gender, ethnicity, as in
Table 2, diabetes, access. No outliers removed from model, N  64. Final model
variables and results: Residual standard error: 2.17 on 59 degrees of freedom.
Multiple R2, 0.298. F-statistic, 6.27 on 4 and 59 degrees of freedom, with a P
value  0.0001.
both nPCR and BMI since both variables are related to
protein energy status; nPCR reflects short-term (recent
dietary intake of protein) while BMI reflects long-stand-
Fig. 3. Relationship between albumin FCR and ceruloplasmin. FCRing energy stores.
8.058 (0.0949 ceruloplasmin); P 0.013. The regression is presented
When absolute albumin turnover was analyzed as the as the least squares fit (solid line) with 95% confidence levels (dashed
lines).response variable using total PCR, absolute plasma vol-
ume and weight as variables the essential relationships
were unchanged (data not shown), suggesting that math-
ematical coupling within the variables was not responsi-
DISCUSSION
ble for the relationship to the response variable, albumin
The reason for studying the mechanisms that changesynthesis. The absolute rate of albumin synthesis was
serum albumin concentration in dialysis patients is thecorrelated with body weight (r  0.507, P  0.001), but
close correlation between hypoalbuminemia and mor-this is anticipated because larger organisms would need
bidity and mortality [1–5]. A low serum albumin hasto maintain a greater steady state rate of synthesis of
been linked to markers of nutrition [16, 25–28] and in-plasma components in order to maintain normal plasma
flammation [21, 22] but this link does not detail mecha-composition in the presence of increased body size.
nisms causing the low serum albumin level. While muchWhen the interactions among albumin synthesis/1.73 m2,
attention has been focused on the regulation of albuminplasma volume (% body weight) and nPCR were exam-
synthesis, alterations in albumin FCR also have been
ined, they were highly significant (Fig. 4A). Similarly,
identified as playing an important role in sustaining albu-
albumin synthesis correlated independently with PV and
min concentration during protein restriction [29, 30]. As
BMI (Fig. 4B). The relationship between the absolute
albumin concentration declines, the normal homeostatic
rate of albumin synthesis and absolute plasma volume response is a decrease in albumin FCR [27]. We did not
was unchanged when weight was used as a variable as find this response in hemodialysis patients but did find
was the relationship between albumin synthesis and PCR that inflammation played an important role in regulating
unadjusted for body weight. When both weight and BMI albumin FCR in this population. This is in agreement
are used as variables BMI, both variables are no longer with observations in rheumatoid arthritis and systemic
significant predictors for (un-normalized) albumin syn- lupus [31]. These data are consistent with the conclusion
thesis rates. The correlation between BMI and albumin that inflammation decreases serum albumin concentra-
synthesis/1.73 m2 (P  0.001) with weight excluded from tion in part by increasing its FCR and by suppressing
the model is stronger than is the relationship between the normal homeostatic relationship between serum al-
the un-normalized rate of albumin synthesis and weight bumin concentration and FCR.
(P  0.023) with BMI excluded from the model. It is of interest that while both ceruloplasmin and
Plasma volume (4.47  0.27 vs. 5.28  0.23%; P  1 AG correlated with albumin FCR, CRP did not. In
0.0126) and nPCR (0.90  0.58 vs. 1.10  0.49; P  cross sectional studies CRP has been correlated with
0.0111) were significantly lower in African Americans, albumin concentration measured contemporaneously,
possibly explaining the lower rate of albumin synthesis yet it has no predictive effect on future albumin levels
in this cohort of patients. [21, 22]. By contrast, both ceruloplasmin and 1 AG
Albumin synthesis was significantly increased in dia- predict future albumin concentration [32], suggesting
betic patients (16.12  0.716 vs. 14.25  0.592 g/1.73 m2/ that whatever process is reflected by ceruloplasmin and
day P  0.354) and in those with AV fistulas compared 1 AG, the influence of this process with albumin con-
centration is different than the process that is reflectedto those with other types of vascular access (P 0.0092).
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Fig. 4. (A) Relationship between albumin synthesis in g/1.73 m2/day, plasma volume in percent body weight (PV%) at the time of the initial
injection of [125I] albumin and normalized protein catabolic rate in g/kg (nPCR). The surface is a best fit model extrapolated using the method of
least squares. The symbols represent values obtained from the individual patients. The vertical line descending from each symbol is to orient the
symbol to the XY plane. Synthesis/1.73 m2/day  7.292  (0.867 * PV(%)  (3.444 * nPCR); r 2  0.259; PV %, P  0.005; nPCR, P  0.007.
(B) Relationship between albumin synthesis in g/1.73m2/day, plasma volume in percent body weight (PV%) at the time of the initial injection of
[125I] albumin and body mass index (BMI). Synthesis/1.73 m2  2.812  [1.803 * PV(%)]  (0.380 * BMI); r 2  0.328 * BMI; PV, P  0.001; BMI,
P  0.001.
by a change in CRP level. While the processes regulating Our measurements produced an average value for al-
bumin FCR, synthesis and distribution of albumin overceruloplasmin and 1 AG act over a long period of time,
processes affecting CRP levels may have a more immedi- a six-week period. The methods were not designed, nor
could they detect rapid shifts of albumin between pools.ate but less long acting effect.
One mechanism whereby inflammation acts to cause It is possible that the effect of the process reflected by
CRP is rapid, such as a shift of albumin from the vascu-hypoalbuminemia is to increase albumin FCR. Since the
half-life of albumin is approximately 14 days, an effect lar to extravascular pool. If that is the case, then the
measurements performed in this study would not detecton catabolism would require a prolonged period of time
to be reflected by a change in serum levels. It is possible these changes.
Age may increase albumin FCR, and contribute tothat we failed to find an effect of CRP levels on albumin
FCR because of the high short-term variation in CRP hypoalbuminemia in elderly, putatively well-nourished
elderly patients [33]. This is relevant because we indeedlevels even within the six-week period of observation,
reducing its statistical power. The value used was the found that age was positively and significantly correlated
with albumin FCR.average obtained over the six-week period and thus the
variability in CRP may have limited its statistical power. Albumin synthesis (adjusted for body surface area)
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Table 5. Determinants of albumin synthesis accompanied adaptation to altitude [37]. Of interest, al-
though the absolute albumin synthetic rate increased sig-Coefficients Value Standard error t value P
nificantly, albumin concentration did not. Thus, plasma(Intercept) 7.216 3.874 1.863 0.068
PV % 1.476 0.328 4.5 0.001 volume expansion may well simulate albumin synthetic
1 AG 0.022 0.011 2.075 0.043 rate as part of a homeostatic mechanism.
nPCR 1.85 1.182 1.565 0.123
Another unexpected relationship was the significantlyBMI 0.339 0.094 3.61 0.001
Age 0.045 0.025 1.815 0.075 reduced rate of albumin synthesis in African American
Ethnicity 1.203 0.518 2.324 0.024 patients. A possible mechanism is that the African Amer-
Potential predictors were PV (%), log. CRP,1 AG ceruloplasmin, transferrin, ican patients studied here also had a significantly lower
nPCR, BMI, age, gender, ethnicity, as in Table 2, diabetes, access. No outliers
nPCR.removed from model, N  64. Final model variables and results: Residual stan-
dard error: 2.64 on 57 degrees of freedom. Multiple R2, 0.472. F-statistic, 8.48 A powerful regulator of albumin synthetic rate is long-
on 6 and 57 degrees of freedom, with a P value  0.0001.
term nutritional status with respect to energy and pro-
tein; either BMI or nPCR powerfully and independently
controlled the rate of albumin synthesis (Fig. 4), whilecorrelated positively with BMI (a nutritional marker)
nPCR alone significantly controlled serum albumin con-and if this factor was eliminated, then it correlated with
centration as did nPCR combined with a marker of in-nPCR. The absolute rate of albumin synthesis correlated
flammation, log CRP (Fig. 1) or1 AG (Fig. 2). This latterpositively with total PCR (the product of body weight
observation is a corroboration of earlier observationsand nPCR) after adjusting statistically for body weight.
[21, 37]. Second, measures of the activity of the acuteThese relationships would be expected from the effect of
phase response that is either reflected in the levels ofnutritional state on protein synthesis [34]. A more dif-
short-lived (CRP) or long-lived (1 AG) proteinsficult relationship to understand was the powerful (and
strongly affected baseline serum albumin concentrationpreviously unknown) relationship between plasma vol-
independently of nutritional variables.ume and albumin synthesis rate: higher plasma volumes
While both the acute phase proteins CRP and 1 AGwere related to higher albumin synthetic rates. This rela-
are inversely correlated with serum albumin concentra-tionship was not due to artifactual mathematical coupling
tion we were unable to demonstrate any statistically sig-[35], since the relationship between albumin synthesis
nificant interaction between the levels of any of the acuteand plasma volume remained even when analyzed with-
phase proteins, either individually or in combination, without adjustment for body size or weight. Perhaps the wide
the rate of albumin synthesis. We previously reported thatrange of plasma volumes found in dialysis patients has
albumin synthesis was significantly less in a group of hemo-uncovered a relationship that was obscured by the small
dialysis patients having serum albumin levels 3.5 g/dLrange of plasma volumes present when kidney function
compared to those with a serum albumin concentrationis intact.
	4.0 g/dL [16]. In that study the levels of acute phaseWe measured albumin turnover rate kinetically by
proteins also were significantly increased in those havingfollowing disappearance of injected [125I] albumin and
the lower albumin concentration. Serum albumin con-plasma volume was measured using the same data. Both
centration in this study was significantly greater than thatare based on knowledge of the dose injected, so an error
reported by us previously [16]. Thus, it is possible that
in the dose administered will cause a change in the same
inflammation also reduces albumin synthesis in hypoal-
direction of both the rate of albumin turnover (synthesis)
buminemic patients.
and plasma volume. It is unlikely that such an error oc-
curred, since the dose administered was counted on sev-
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